查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828148

2025年鼻腔給藥技術全球市場報告

Nasal Drug Delivery Technology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，鼻腔給藥技術市場規模強勁成長，從2024年的807.9億美元增加至2025年的852.3億美元，複合年成長率為5.5%。這段歷史時期的成長可歸因於藥物製劑的進步、呼吸系統疾病盛行率的上升、患者對非侵入性給藥方式的偏好、老年人口的不斷成長以及監管機構對鼻腔給藥核准的支持。

預計未來幾年，鼻腔給藥技術市場將強勁成長，到2029年將達到1,182.2億美元，年複合成長率（CAGR）為8.5%。預測期內的成長可歸因於生技藥品和胜肽類療法的興起、對兒科和老年患者需求的關注、製藥行業內的聯盟與合作、非處方 (OTC) 鼻腔產品的擴張以及對精準醫療的日益關注。預測期內的主要趨勢包括製劑技術的進步、對患者友善設備的日益關注、治療領域的拓展、生技藥品和胜肽給藥以及滴鼻劑技術的創新。

鼻腔給藥技術旨在透過鼻腔給藥，將藥物在血液中的濃度迅速提高到治療水平，有可能實現透過嗅覺神經元將藥物直接輸送到大腦，繞過血腦障壁（BBB）並最大限度地減少肝臟和腸道的處理。

此技術的主要劑型包括滴鼻劑、滴鼻劑、鼻凝膠、軟膏和粉末。滴鼻劑噴出大量細小液滴，沖洗鼻腔並將藥物輸送至全身。它們有加壓和非加壓兩種包裝，用途廣泛，包括治療過敏性和非過敏性鼻炎、鼻塞、氣喘和疫苗接種。這些產品可透過各種分銷管道購買，包括醫院藥房、零售店和線上藥房，並供最終用戶使用，包括居家醫療機構和醫院。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司最新報告系列的一部分，該系列提供了您在鼻腔給藥技術行業取得成功所需的所有數據，涵蓋鼻腔給藥技術市場統計數據，例如全球市場規模、區域佔有率、鼻腔給藥技術市場佔有率的競爭對手、詳細的鼻腔給藥技術細分市場、市場趨勢和商業機會。本鼻腔給藥技術市場研究報告提供了完整的行業觀點，並深入分析了該行業的現狀和未來前景。

未來五年8.5%的預測成長率，較我們先前對該市場的預測略有下降0.1%。下降主要源自於美國與其他國家之間關稅的影響。這直接影響了美國，包括對德國精密噴霧噴嘴的貿易限制，從而提高了滴鼻劑的生產成本，並可能推遲治療方法偏頭痛和荷爾蒙療法的新方法。由於互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響，其影響也將更加廣泛。

慢性病盛行率的上升預計將推動鼻腔給藥技術市場的成長。慢性病是指持續時間超過一年、需要持續醫療照護並可能限制日常活動的健康狀況。鼻腔給藥技術用於治療慢性鼻竇炎，透過針對鼻腔複雜結構量身定做的治療方法，增強細菌生物膜管理和黏膜清除。例如，根據總部位於美國的非營利醫療組織美國心臟病學會 2022 年 8 月發布的報告，預計從 2025 年到 2060 年，所有四大心血管危險因子都將增加。尤其是糖尿病，預計增加 39.3%，達到 5,500 萬例。其次是血脂異常症（增加 27.6%，達到 1.26 億例）、高血壓（增加 25.1%，達到 1.62 億例）和肥胖（增加 18.3%，達到 1.26 億例）。此外，心血管疾病預計也將大幅成長，包括中風（成長33.8%，達到1,500萬）、心臟衰竭（成長33.4%，達到1,300萬）、缺血性心臟疾病（成長30.7%，達到2,900萬）以及心臟病發作（成長16.9%，達到1,600萬）。因此，慢性病盛行率的上升正在推動鼻腔給藥系統市場的擴張。

預計全球老年人口（通常為 65 歲及以上）的不斷成長將推動鼻腔給藥技術市場的成長。這種給藥方式由於其易於使用且患者依從性更高，有助於克服該年齡層面臨的吞嚥藥丸困難，在老年人中越來越受歡迎。例如，2024 年 1 月，專注於收集和提供統計數據的美國非營利組織人口研究所預測，65 歲及以上美國的數量將增加 47%，從 2022 年的 5800 萬增加到 2050 年的 8,200 萬。此外，65 歲及以上人口的比例預計將從 17% 上升到 23%。因此，全球老年人口的成長將有助於鼻腔給藥技術市場的擴張。

產品創新是塑造鼻腔給藥技術格局的關鍵趨勢。領先的製藥公司正在積極開發新型給藥方法，以鞏固其市場地位。例如，2023年1月，阿普塔集團（AptarGroup, Inc.）推出了APF Futurity，這是首款可回收、無金屬、多鼻噴霧，專為生理食鹽水和同等非處方藥（OTC）製劑設計。這款創新產品的可回收設計已獲得AA級認證，有助於提高回收效率。

此次技術進步的合作彰顯了公司在鼻腔給藥領域的策略重點。具體而言，2023年11月，Hobbione與工業設計顧問公司（IDC）合作開發了先進的鼻腔粉末給藥裝置。這些裝置提供精準的給藥方案—局部、全身給藥或鼻-腦給藥—並展現出多功能性和可靠性。此次合作旨在加速兩款創新型鼻腔粉劑給藥裝置的上市，以滿足多樣化的給藥需求，並簡化藥物開發和生產流程。

2022年5月，美國醫療設備製造商Medtronic Inc.）收購了Intersect ENT Inc.，收購金額未揭露。此次收購為Medtronic的整體耳鼻喉 (ENT) 產品組合增添了用於改善鼻竇手術後療效和治療鼻息肉的新產品。 Intersect ENT Inc. 是一家總部位於美國的耳鼻喉醫療設備製造商。

鼻腔給藥技術市場的主要企業包括 AptarGroup Inc.、Becton Dickinson and Company、GlaxoSmithKline plc、Johnson & Johnson Private Limited、Novartis AG、Pfizer Inc.、3M Company、Cadila Healthcare Limited、Neurelis Inc.、OptiNose Inc.、Bausch Health Companies Inc.、Nave Ltd. Pharmaceuticals Ltd.、ENT Technologies Pty. Ltd.、Merck & Co. Inc.、Sanofi SA、AstraZeneca plc、Boehringer Ingelheim International GmbH、Bayer AG、Abbott Laboratories、Eli Lilly and Company、Bristol-Myers Squibb 工業, Pharmaceutical plc、Regeneron Pharmaceuticals Inc. 與 Alexion Pharmaceuticals Inc.

2024 年，北美是鼻腔給藥技術市場最大的地區。鼻腔給藥技術市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美以及中東和非洲。

鼻腔給藥技術市場報告涵蓋以下國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利、西班牙

鼻腔給藥技術市場由提供鼻腔給藥服務、腦部標靶治療和黏膜疫苗接種等服務的營業單位所獲得的收益所構成。市場價值包括服務提供者銷售的或包含在其服務產品中的相關產品的價值。鼻腔給藥技術市場還包括用於提供鼻腔給藥技術服務的導管輸送藥物、霧化器和壓力定量吸入器 (PMDI) 設備的銷售。該市場的價值為“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球鼻腔給藥技術：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球鼻腔給藥技術市場：成長率分析
  • 全球鼻腔給藥技術市場表現：規模與成長，2019-2024
  • 全球鼻腔給藥技術市場預測：規模與成長，2024-2029年，2034年
  • 全球鼻腔給藥技術：總目標市場（TAM）

第6章 市場細分

  • 全球鼻腔給藥技術市場（依劑型分類）：2019-2024 年、2024-2029 年、2034 年表現及預測
  • 鼻噴劑
  • 滴鼻劑
  • 鼻用凝膠和軟膏
  • 鼻粉
  • 其他劑型
  • 全球鼻腔給藥技術市場（按容器類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 壓力容器
  • 非加壓容器
  • 全球鼻腔給藥技術市場（依治療應用、效能與預測），2019-2024 年、2024-2029 年、2034 年
  • 過敏性和非過敏性鼻炎
  • 鼻塞
  • 氣喘
  • 疫苗接種
  • 其他治療用途
  • 全球經鼻給藥技術市場（依分銷管道）：2019-2024 年、2024-2029 年、2034 年業績及預測
  • 醫院藥房
  • 零售藥局
  • 網路藥局
  • 全球鼻腔給藥技術市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 居家照護環境
  • 醫院
  • 全球鼻腔給藥技術市場：依鼻噴劑類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 定量噴霧
  • 非定量噴霧
  • 全球鼻腔給藥技術市場：滴鼻劑類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 液態滴鼻劑
  • 凝膠型滴鼻劑
  • 全球鼻腔給藥技術市場：依鼻腔凝膠及軟膏（按類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 水凝膠配方
  • 油性軟膏
  • 全球鼻腔給藥技術市場：依鼻腔粉末類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 乾粉吸入器（DPI）
  • 噴霧乾燥粉末
  • 全球鼻腔給藥技術市場：依其他劑型（按類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 鼻貼
  • 鼻插入物

第7章 區域和國家分析

  • 全球鼻腔給藥技術市場：依地區、績效及預測，2019-2024年、2024-2029年、2034年
  • 全球鼻腔給藥技術市場：國家、績效與預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 鼻腔給藥技術市場：競爭格局
  • 鼻腔給藥技術市場：公司簡介
    • AptarGroup Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Pfizer Inc.
  • 3M Company
  • Cadila Healthcare Limited
  • Neurelis Inc.
  • OptiNose Inc.
  • Bausch Health Companies Inc.
  • Naveh Pharma Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Consort Medical plc
  • Douglas Pharmaceuticals Ltd.
  • ENT Technologies Pty. Ltd.
  • Merck & Co. Inc.
  • Sanofi SA
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年鼻腔給藥技術市場：提供新機會的國家
  • 2029年鼻腔給藥技術市場：細分領域帶來新機會
  • 2029年鼻腔給藥技術市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r24358u

Nasal drug delivery technology involves administering pharmaceuticals through the nasal cavity, aiming to rapidly achieve therapeutic drug levels in the bloodstream and potentially enable direct drug delivery to the brain via olfactory neurons. This method bypasses the blood-brain barrier (BBB) and undergoes minimal processing in the liver and intestines.

Key dosage forms for this technology include nasal spray, nasal drops, nasal gels, ointments, powders, and others. Nasal spray devices expel numerous tiny liquid drops to cleanse the nose or deliver medication to the body. They are available in pressurized and non-pressurized containers and are applied across diverse uses such as allergic and non-allergic rhinitis, nasal congestion, asthma, vaccination, and more. These products are accessible through various distribution channels such as hospital pharmacies, retail outlets, and online pharmacies, and are utilized by end-users including home care settings and hospitals.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The nasal drug delivery technology market research report is one of a series of new reports from The Business Research Company that provides nasal drug delivery technology market statistics, including nasal drug delivery technology industry global market size, regional shares, competitors with a nasal drug delivery technology market share, detailed nasal drug delivery technology market segments, market trends, and opportunities, and any further data you may need to thrive in the nasal drug delivery technology industry. This nasal drug delivery technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nasal drug delivery technology market size has grown strongly in recent years. It will grow from $80.79 billion in 2024 to $85.23 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to advancements in drug formulations, increasing prevalence of respiratory disorders, patient preference for non-invasive delivery, expanding geriatric population, regulatory support for nasal drug approvals.

The nasal drug delivery technology market size is expected to see strong growth in the next few years. It will grow to $118.22 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to rise in biologics and peptide therapies, focus on pediatric and geriatric patient needs, partnerships and collaborations in the pharma industry, expansion of over-the-counter (OTC) nasal products, increased focus on precision medicine. Major trends in the forecast period include advancements in formulation technology, increased focus on patient-friendly devices, expansion of therapeutic areas, biologics and peptides delivery, innovations in nasal spray technologies.

The forecast of 8.5% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through trade restrictions on precision spray nozzles from Germany, raising production costs for nasal mist medications and delaying new treatments for migraines and hormone therapies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of chronic diseases is projected to stimulate growth in the nasal drug delivery technology market. Chronic diseases are defined as health conditions that persist for a year or more and necessitate continuous medical care, potentially limiting daily activities. Nasal drug delivery technologies are utilized to manage chronic rhinosinusitis, enhancing bacterial biofilm management and mucociliary clearance through a therapeutic approach tailored for the intricate structure of the nasal cavity. For example, a report by the American College of Cardiology, a nonprofit medical association based in the United States, published in August 2022, indicates that all four primary cardiovascular risk factors are expected to rise from 2025 to 2060. Among these, diabetes is anticipated to experience the most significant increase, rising by 39.3% to reach 55 million individuals. This is followed by dyslipidemia (up 27.6% to 126 million), hypertension (up 25.1% to 162 million), and obesity (up 18.3% to 126 million). Furthermore, substantial rises in cardiovascular disease rates are expected, including stroke (33.8% increase to 15 million) and heart failure (33.4% increase to 13 million), with ischemic heart disease (up 30.7% to 29 million) and heart attack (up 16.9% to 16 million) not far behind. As a result, the increasing prevalence of chronic diseases is fueling the expansion of the nasal drug delivery systems market.

The growth of the nasal drug delivery technology market is anticipated to be driven by the increasing global geriatric population. The geriatric population consists of individuals who are generally 65 years old and above. This drug delivery method is favored among older adults due to its ease of use and improved patient adherence, helping to overcome difficulties associated with pill swallowing in this age group. For example, in January 2024, the Population Reference Bureau, a nonprofit organization in the US that focuses on collecting and providing statistics, projected that the number of Americans aged 65 and older will grow from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, the proportion of the population aged 65 and older is expected to rise from 17% to 23%. Consequently, the increase in the geriatric population worldwide will contribute to the expansion of the nasal drug delivery technology market.

Product innovation stands as a pivotal trend shaping the landscape of nasal drug delivery technology. Leading pharmaceutical companies are actively engaged in developing novel drug administration methods to bolster their market positions. For instance, in January 2023, AptarGroup, Inc. introduced APF Futurity, the first recyclable, metal-free, multidose nasal spray designed for nasal saline and equivalent OTC formulations. This innovative product's recyclability design has garnered Class AA certification, promoting greater recycling efficiency.

Collaborative efforts aimed at technological advancements highlight the strategic focus within the nasal drug delivery sector. Notably, in November 2023, Hovione collaborated with Industrial Design Consultancy (IDC) to develop advanced nasal powder delivery devices. These devices offer precise drug delivery options for local, systemic, or nose-to-brain applications, showcasing versatility and reliability. The collaboration's objective is to expedite the release of two innovative nasal powder delivery devices, catering to diverse drug delivery needs while streamlining drug product development and manufacturing processes.

In May 2022, Medtronic plc, a US-based medical device firm, acquired Intersect ENT Inc. for an undisclosed sum. The acquisition will add novel products used in sinus operations to enhance post-operative outcomes and treat nasal polyps to Medtronic's entire ear, nose, and throat (ENT) portfolio. Intersect ENT Inc. is a US-based medical device firm operating in ear, nose, and throat medical technology.

Major companies operating in the nasal drug delivery technology market include AptarGroup Inc., Becton Dickinson and Company, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Novartis AG, Pfizer Inc., 3M Company, Cadila Healthcare Limited, Neurelis Inc., OptiNose Inc., Bausch Health Companies Inc., Naveh Pharma Ltd., Teva Pharmaceutical Industries Ltd., Consort Medical plc, Douglas Pharmaceuticals Ltd., ENT Technologies Pty. Ltd., Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Boehringer Ingelheim International GmbH, Bayer AG, Abbott Laboratories, Eli Lilly and Company, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Amgen Inc., Gilead Sciences Inc., Biogen Inc., Roche Holding AG, Allergan plc, Regeneron Pharmaceuticals Inc., Alexion Pharmaceuticals Inc.

North America was the largest region in the nasal drug delivery technology market in 2024. The regions covered in the nasal drug delivery technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the nasal drug delivery technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The nasal drug delivery technology market consists of revenues earned by entities by providing services such as intranasal drug delivery services, brain-targeted therapy, and mucosal vaccination. The market value includes the value of related goods sold by the service provider or included within the service offering. The nasal drug delivery technology market also includes sales of catheter-delivered drugs, nebulizers, and pressurized metered-dose inhalers (PMDIs) equipment which are used in providing nasal drug delivery technology services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nasal Drug Delivery Technology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nasal drug delivery technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nasal drug delivery technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nasal drug delivery technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Dosage Form: Nasal Spray; Nasal Drops; Nasal Gels And Ointments; Nasal Powders; Other Dosage Forms
  • 2) By Container Type: Pressurized Containers; Non-Pressurized Containers
  • 3) By Therapeutic Application: Allergic And Non-Allergic Rhinitis; Nasal Congestion; Asthma; Vaccination; Other Therapeutic Applications
  • 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • 5) By End User: Home Care Settings; Hospitals
  • Subsegments:
  • 1) By Nasal Spray: Metered-Dose Spray; Non-Metered-Dose Spray
  • 2) By Nasal Drops: Liquid Nasal Drops; Gel-Based Nasal Drops
  • 3) By Nasal Gels and Ointments: Hydrogel Formulations; Oil-Based Ointments
  • 4) By Nasal Powders: Dry Powder Inhalers (DPI); Spray-Dried Powders
  • 5) By Other Dosage Forms: Nasal Patches; Nasal Inserts
  • Companies Mentioned: AptarGroup Inc.; Becton Dickinson and Company; GlaxoSmithKline plc; Johnson & Johnson Private Limited; Novartis AG; Pfizer Inc.; 3M Company; Cadila Healthcare Limited; Neurelis Inc.; OptiNose Inc.; Bausch Health Companies Inc.; Naveh Pharma Ltd.; Teva Pharmaceutical Industries Ltd.; Consort Medical plc; Douglas Pharmaceuticals Ltd.; ENT Technologies Pty. Ltd.; Merck & Co. Inc.; Sanofi SA; AstraZeneca plc; Boehringer Ingelheim International GmbH; Bayer AG; Abbott Laboratories; Eli Lilly and Company; Bristol-Myers Squibb Company; Takeda Pharmaceutical Company Limited; Amgen Inc.; Gilead Sciences Inc.; Biogen Inc.; Roche Holding AG; Allergan plc; Regeneron Pharmaceuticals Inc.; Alexion Pharmaceuticals Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nasal Drug Delivery Technology Market Characteristics

3. Nasal Drug Delivery Technology Market Trends And Strategies

4. Nasal Drug Delivery Technology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Nasal Drug Delivery Technology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Nasal Drug Delivery Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Nasal Drug Delivery Technology Market Growth Rate Analysis
  • 5.4. Global Nasal Drug Delivery Technology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Nasal Drug Delivery Technology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Nasal Drug Delivery Technology Total Addressable Market (TAM)

6. Nasal Drug Delivery Technology Market Segmentation

  • 6.1. Global Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nasal Spray
  • Nasal Drops
  • Nasal Gels And Ointments
  • Nasal Powders
  • Other Dosage Forms
  • 6.2. Global Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pressurized Containers
  • Non-Pressurized Containers
  • 6.3. Global Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Allergic And Non-Allergic Rhinitis
  • Nasal Congestion
  • Asthma
  • Vaccination
  • Other Therapeutic Applications
  • 6.4. Global Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • 6.5. Global Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Home Care Settings
  • Hospitals
  • 6.6. Global Nasal Drug Delivery Technology Market, Sub-Segmentation Of Nasal Spray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metered-Dose Spray
  • Non-Metered-Dose Spray
  • 6.7. Global Nasal Drug Delivery Technology Market, Sub-Segmentation Of Nasal Drops, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid Nasal Drops
  • Gel-Based Nasal Drops
  • 6.8. Global Nasal Drug Delivery Technology Market, Sub-Segmentation Of Nasal Gels and Ointments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hydrogel Formulations
  • Oil-Based Ointments
  • 6.9. Global Nasal Drug Delivery Technology Market, Sub-Segmentation Of Nasal Powders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dry Powder Inhalers (DPI)
  • Spray-Dried Powders
  • 6.10. Global Nasal Drug Delivery Technology Market, Sub-Segmentation Of Other Dosage Forms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nasal Patches
  • Nasal Inserts

7. Nasal Drug Delivery Technology Market Regional And Country Analysis

  • 7.1. Global Nasal Drug Delivery Technology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Nasal Drug Delivery Technology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nasal Drug Delivery Technology Market

  • 8.1. Asia-Pacific Nasal Drug Delivery Technology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nasal Drug Delivery Technology Market

  • 9.1. China Nasal Drug Delivery Technology Market Overview
  • 9.2. China Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nasal Drug Delivery Technology Market

  • 10.1. India Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nasal Drug Delivery Technology Market

  • 11.1. Japan Nasal Drug Delivery Technology Market Overview
  • 11.2. Japan Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nasal Drug Delivery Technology Market

  • 12.1. Australia Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nasal Drug Delivery Technology Market

  • 13.1. Indonesia Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nasal Drug Delivery Technology Market

  • 14.1. South Korea Nasal Drug Delivery Technology Market Overview
  • 14.2. South Korea Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nasal Drug Delivery Technology Market

  • 15.1. Western Europe Nasal Drug Delivery Technology Market Overview
  • 15.2. Western Europe Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nasal Drug Delivery Technology Market

  • 16.1. UK Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nasal Drug Delivery Technology Market

  • 17.1. Germany Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nasal Drug Delivery Technology Market

  • 18.1. France Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nasal Drug Delivery Technology Market

  • 19.1. Italy Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nasal Drug Delivery Technology Market

  • 20.1. Spain Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nasal Drug Delivery Technology Market

  • 21.1. Eastern Europe Nasal Drug Delivery Technology Market Overview
  • 21.2. Eastern Europe Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nasal Drug Delivery Technology Market

  • 22.1. Russia Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nasal Drug Delivery Technology Market

  • 23.1. North America Nasal Drug Delivery Technology Market Overview
  • 23.2. North America Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nasal Drug Delivery Technology Market

  • 24.1. USA Nasal Drug Delivery Technology Market Overview
  • 24.2. USA Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nasal Drug Delivery Technology Market

  • 25.1. Canada Nasal Drug Delivery Technology Market Overview
  • 25.2. Canada Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nasal Drug Delivery Technology Market

  • 26.1. South America Nasal Drug Delivery Technology Market Overview
  • 26.2. South America Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nasal Drug Delivery Technology Market

  • 27.1. Brazil Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nasal Drug Delivery Technology Market

  • 28.1. Middle East Nasal Drug Delivery Technology Market Overview
  • 28.2. Middle East Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nasal Drug Delivery Technology Market

  • 29.1. Africa Nasal Drug Delivery Technology Market Overview
  • 29.2. Africa Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nasal Drug Delivery Technology Market Competitive Landscape And Company Profiles

  • 30.1. Nasal Drug Delivery Technology Market Competitive Landscape
  • 30.2. Nasal Drug Delivery Technology Market Company Profiles
    • 30.2.1. AptarGroup Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Nasal Drug Delivery Technology Market Other Major And Innovative Companies

  • 31.1. Pfizer Inc.
  • 31.2. 3M Company
  • 31.3. Cadila Healthcare Limited
  • 31.4. Neurelis Inc.
  • 31.5. OptiNose Inc.
  • 31.6. Bausch Health Companies Inc.
  • 31.7. Naveh Pharma Ltd.
  • 31.8. Teva Pharmaceutical Industries Ltd.
  • 31.9. Consort Medical plc
  • 31.10. Douglas Pharmaceuticals Ltd.
  • 31.11. ENT Technologies Pty. Ltd.
  • 31.12. Merck & Co. Inc.
  • 31.13. Sanofi SA
  • 31.14. AstraZeneca plc
  • 31.15. Boehringer Ingelheim International GmbH

32. Global Nasal Drug Delivery Technology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nasal Drug Delivery Technology Market

34. Recent Developments In The Nasal Drug Delivery Technology Market

35. Nasal Drug Delivery Technology Market High Potential Countries, Segments and Strategies

  • 35.1 Nasal Drug Delivery Technology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Nasal Drug Delivery Technology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Nasal Drug Delivery Technology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer